Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA says Eli Lilly weight loss drug shortage is over
US FDA says Lilly's weight-loss drug shortage is resolved
The U.S. Food and Drug Administration on Thursday found that there was no longer a shortage of Eli Lilly's blockbuster weight loss and diabetes drugs following a re-evaluation of their supply by the agency.
Prices on weight loss drugs are dropping — What patients need to know
Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr. Faith Coleman explains.
Lilly’s US Weight-Loss Drug Shortage Ends, Curtailing Copycats
Eli Lilly & Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which means compounding pharmacies must stop making less expensive copycat versions in the coming months.
Medpage Today on MSN
3d
Newer Diabetes Drugs Still Under-Prescribed in High-Risk Patients
NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic ...
2d
Better Than Metformin: New Diabetes Wonder-Drug Slashes Fat and Blood Sugar
HPH-15, a compound developed by Kumamoto University, reduces blood glucose and fat accumulation more effectively than ...
News Medical on MSN
11d
New compound HPH-15 offers promising alternative to diabetes medications
Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and ...
StudyFinds on MSN
6d
Scientists close to creating ‘simple pill’ that cures diabetes
Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...
FierceBiotech
2d
Biomea's diabetes drug improves glucose control 3 months after FDA hold lifted
Biomea also drilled down into subgroups of patients with mild age-related diabetes and severe insulin-deficient diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback